Inactive Provider
This provider's NPI has been deactivated on 05/06/2026. The information on this page is historical and may no longer be current.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $245.96 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $78.71 | 4 | $0 (2024) |
| Novo Nordisk Inc | $64.23 | 4 | $0 (2020) |
| Shire North American Group Inc | $33.72 | 2 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $25.88 | 2 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $16.12 | 1 | $0 (2019) |
| PFIZER INC. | $13.92 | 1 | $0 (2022) |
| Allergan Inc. | $13.38 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $56.91 | 3 | Lilly USA, LLC ($56.91) |
| 2022 | $13.92 | 1 | PFIZER INC. ($13.92) |
| 2020 | $64.23 | 4 | Novo Nordisk Inc ($64.23) |
| 2019 | $29.50 | 2 | SANOFI-AVENTIS U.S. LLC ($16.12) |
| 2018 | $68.94 | 4 | Shire North American Group Inc ($33.72) |
| 2017 | $12.46 | 1 | Merck Sharp & Dohme Corporation ($12.46) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Diabetes | ||||||
| 01/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Diabetes | ||||||
| 06/07/2022 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: VACCINES | ||||||
| 08/13/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Diabetes | ||||||
| 02/12/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Diabetes | ||||||
| 02/11/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Diabetes | ||||||
| 01/16/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Diabetes | ||||||
| 10/11/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: DIABETES | ||||||
| 08/09/2018 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Diabetes | ||||||
| 07/27/2018 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/12/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2017 | Merck Sharp & Dohme Corporation | ZOSTAVAX (Biological), PNEUMOVAX 23, GARDASIL9 | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: VACCINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 378 | 522 | $111,982 | $23,234 |
| 2022 | 9 | 347 | 529 | $97,450 | $18,891 |
| 2021 | 7 | 371 | 535 | $105,503 | $26,938 |
| 2020 | 11 | 515 | 684 | $123,684 | $28,362 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 121 | $39,241 | $5,267 | 13.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 111 | $24,493 | $4,669 | 19.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $11,912 | $4,234 | 35.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 34 | 35 | $6,654 | $2,507 | 37.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 45 | 45 | $14,535 | $2,165 | 14.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 37 | 38 | $1,520 | $1,218 | 80.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 24 | $3,204 | $971.02 | 30.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 48 | 94 | $3,196 | $894.88 | 28.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $6,517 | $803.96 | 12.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 15 | $600.00 | $480.75 | 80.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 11 | $110.00 | $24.20 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 159 | $49,860 | $7,374 | 14.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 103 | $22,094 | $4,222 | 19.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 37 | 38 | $6,436 | $2,598 | 40.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 34 | 34 | $10,982 | $1,444 | 13.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 41 | 43 | $1,720 | $1,353 | 78.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 19 | 22 | $2,850 | $916.31 | 32.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 48 | 92 | $3,128 | $882.55 | 28.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 24 | 24 | $240.00 | $53.30 | 22.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 11 | 14 | $140.00 | $48.42 | 34.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 71 | 71 | $22,296 | $10,023 | 45.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 88 | 173 | $53,284 | $8,901 | 16.7% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 43 | 44 | $6,926 | $2,863 | 41.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 73 | $15,257 | $2,803 | 18.4% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 56 | 109 | $3,592 | $1,058 | 29.5% |
About Dr. Pedro Solanet, MD
Dr. Pedro Solanet, MD is a Family Medicine healthcare provider based in Kennett Square, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437112554.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pedro Solanet, MD has received a total of $245.96 in payments from pharmaceutical and medical device companies, with $56.91 received in 2024. These payments were reported across 15 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($245.96).
As a Medicare-enrolled provider, Solanet has provided services to 1,611 Medicare beneficiaries, totaling 2,270 services with total Medicare billing of $97,425. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Kennett Square, PA
- Active Since 04/10/2006
- Last Updated 01/04/2026
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1437112554
Products in Payments
- Ozempic (Drug) $64.23
- MOUNJARO (Drug) $56.91
- TRULICITY (Drug) $21.80
- VYVANSE (Drug) $18.21
- SOLIQUA 100/33 (Drug) $16.12
- MYDAYIS (Drug) $15.51
- PREVNAR 20 (Biological) $13.92
- JANUVIA (Drug) $13.42
- VRAYLAR (Drug) $13.38
- ZOSTAVAX (Biological) $12.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Kennett Square
Dr. Sony John, Md, MD
Family Medicine — Payments: $2,998
Matthew Pagano, D.o, D.O
Family Medicine — Payments: $2,180
Elaine Kirchdoerfer, Md, MD
Family Medicine — Payments: $316.55
Steven Ginsburg, Do, DO
Family Medicine — Payments: $188.83
Michael Welsh, Do, DO
Family Medicine — Payments: $172.85
Cheryl Hlavac, Md, MD
Family Medicine — Payments: $124.68